Literature DB >> 24743136

End-tidal carbon monoxide and hemolysis.

G F Tidmarsh1, R J Wong1, D K Stevenson1.   

Abstract

Hemolytic disease in newborns can result from a number of conditions, which can place such infants at an increased risk for the development of severe hyperbilirubinemia. Because the catabolism of heme produces equimolar amounts of carbon monoxide (CO) and bilirubin, measurements of end-tidal breath CO (corrected for ambient CO) or ETCOc can serve as an index of hemolysis as well as of bilirubin production from any cause. Elevated levels of ETCOc have been correlated with blood carboxyhemoglobin levels and thus hemolysis. However, the detection of hemolysis can be a clinically challenging problem in newborns. Here, we describe the importance of determining ETCOc levels and their application in identifying infants at risk for developing hyperbilirubinemia associated with hemolysis and other causes of increased bilirubin production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743136     DOI: 10.1038/jp.2014.66

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  38 in total

1.  Interaction of hemolysis and hyperbilirubinemia on neurodevelopmental outcomes in the collaborative perinatal project.

Authors:  Michael Kuzniewicz; Thomas B Newman
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

2.  A practical method for estimating carboxyhaemoglobin by alveolar air analysis.

Authors:  T SJOSTRAND
Journal:  Overseas Postgrad Med J       Date:  1948-07

3.  A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus.

Authors:  V K Bhutani; L Johnson
Journal:  J Perinatol       Date:  2009-02       Impact factor: 2.521

Review 4.  A global need for affordable neonatal jaundice technologies.

Authors:  Tina M Slusher; Alvin Zipursky; Vinod K Bhutani
Journal:  Semin Perinatol       Date:  2011-06       Impact factor: 3.300

5.  Jaundice in the healthy newborn infant: a new approach to an old problem.

Authors:  M J Maisels; K Gifford; C E Antle; G R Leib
Journal:  Pediatrics       Date:  1988-04       Impact factor: 7.124

6.  Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system.

Authors:  H J Vreman; R J Wong; C A Sanesi; P A Dennery; D K Stevenson
Journal:  Can J Physiol Pharmacol       Date:  1998-12       Impact factor: 2.273

Review 7.  Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND).

Authors:  Steven M Shapiro
Journal:  J Perinatol       Date:  2005-01       Impact factor: 2.521

8.  Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adults.

Authors:  H J Vreman; R J Wong; P Harmatz; A A Fanaroff; B Berman; D K Stevenson
Journal:  J Clin Monit Comput       Date:  1999-12       Impact factor: 2.502

9.  Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.

Authors:  Michael Kaplan; Marguerite Herschel; Cathy Hammerman; James D Hoyer; David K Stevenson
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

10.  Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway.

Authors:  Laura Cesaratto; Sebastian D Calligaris; Carlo Vascotto; Marta Deganuto; Cristina Bellarosa; Franco Quadrifoglio; J Donald Ostrow; Claudio Tiribelli; Gianluca Tell
Journal:  J Mol Med (Berl)       Date:  2007-05-04       Impact factor: 4.599

View more
  6 in total

1.  A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.

Authors:  N Scott Reading; José A Ruiz-Bonilla; Robert D Christensen; William Cáceres-Perkins; Josef T Prchal
Journal:  Am J Hematol       Date:  2017-03-24       Impact factor: 10.047

2.  Bilirubin production and hour-specific bilirubin levels.

Authors:  V K Bhutani; R J Wong; H J Vreman; D K Stevenson
Journal:  J Perinatol       Date:  2015-04-16       Impact factor: 2.521

3.  A new method to evaluate macaque health using exhaled breath: A case study of M. tuberculosis in a BSL-3 setting.

Authors:  Theodore R Mellors; Lionel Blanchet; JoAnne L Flynn; Jaime Tomko; Melanie O'Malley; Charles A Scanga; Philana L Lin; Jane E Hill
Journal:  J Appl Physiol (1985)       Date:  2017-01-05

4.  Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.

Authors:  V K Bhutani; R Poland; L D Meloy; T Hegyi; A A Fanaroff; M J Maisels
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

5.  Hemolysis during and after 21 days of head-down-tilt bed rest.

Authors:  Guy Trudel; Hans K Uhthoff; Odette Laneuville
Journal:  Physiol Rep       Date:  2017-12

6.  Determinants of Carboxyhemoglobin Levels and Relationship with Sepsis in a Retrospective Cohort of Preterm Neonates.

Authors:  Andrew J McArdle; James Webbe; Kathleen Sim; Graham Parrish; Clive Hoggart; Yifei Wang; J Simon Kroll; Sunit Godambe; Aubrey J Cunnington
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.